Sennoside B

CAT:
804-HY-N0366-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Sennoside B - image 1

Sennoside B

  • Description:

    Sennoside B is a potent and orally active platelet-derived growth factor (PDGF) inhibitor. Sennoside B inhibits cell proliferation and the expression of phosphorylation of PDGFR-β, STAT-5, AKT and ERK induced by PDGF-BB. Sennoside B shows gastroprotective activities. Sennoside B has the potential for the research of gastritis[1][2].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H315, H319, H335
  • Target:

    PDGFR
  • Type:

    Natural Products
  • Related Pathways:

    Protein Tyrosine Kinase/RTK
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/sennoside-b.html
  • Purity:

    99.23
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O[C@@H]1[C@@H](O)[C@H](OC2=C(C(C(C(O)=CC(C(O)=O)=C3)=C3[C@]4([C@@]5(C(C=CC=C6O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)=C6C(C8=C5C=C(C(O)=O)C=C8O)=O)[H])[H])=O)C4=CC=C2)O[C@H](CO)[C@H]1O
  • Molecular Formula:

    C42H38O20
  • Molecular Weight:

    862.74
  • Precautions:

    H315, H319, H335
  • References & Citations:

    [1]Hwang IY, et al. Gastroprotective Activities of Sennoside A and Sennoside B via the Up-Regulation of Prostaglandin E2 and the Inhibition of H (+) /K (+) -ATPase. Biomol Ther (Seoul) . 2015 Sep;23 (5) :458-64.|[2]Chen YC, et al. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells. Life Sci. 2009 Jun 19;84 (25-26) :915-22.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture and light)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    No Development Reported
  • CAS Number:

    [128-57-4]